These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 13963446)

  • 1. [Excipients and toxicity].
    GUILLOT B
    Prod Pharm; 1962 Sep; 17():480-1. PubMed ID: 13963446
    [No Abstract]   [Full Text] [Related]  

  • 2. Water-soluble synthetic polymers in immunology and biomedicine.
    Molyneux P
    Asian Pac J Allergy Immunol; 1984 Dec; 2(2):301-10. PubMed ID: 6398087
    [No Abstract]   [Full Text] [Related]  

  • 3. [POTENTIATION OF GONADOTROPIC ACTIVITY WITH DELAYED-ACTION VEHICLES AND DIFFUSING FACTORS (HYALURONIDASE)].
    ORLANDI F; FIGUS E; ABATE G; DELGIUDICE G
    Endocrinol Sci Cost; 1964; 28():59-64. PubMed ID: 14196899
    [No Abstract]   [Full Text] [Related]  

  • 4. [USE OF POLYVINYLPYRROLIDONE AND POLYVINYL ALCOHOL AS BINDING SUBSTANCES IN THE PRODUCTION OF TABLETS].
    NOSOVYTSKA SA; BORZUNOV EE; OHIENKO VP; BORYSENKO IuB
    Farm Zh; 1964; 19():41-5. PubMed ID: 14221843
    [No Abstract]   [Full Text] [Related]  

  • 5. Stability of cyclophosphamide in lyophilized cakes. II. Urea, polyvinylpyrrolidone, and dextran as excipients.
    Kovalcik TR; Guillory JK
    J Parenter Sci Technol; 1988; 42(5):165-73. PubMed ID: 2462038
    [No Abstract]   [Full Text] [Related]  

  • 6. THE FRACTIONATION OF PROTEIN MIXTURES BY LINEAR POLYMERS OF HIGH MOLECULAR WEIGHT.
    POLSON A; POTGIETER GM; LARGIER JF; MEARS GE; JOUBERT FJ
    Biochim Biophys Acta; 1964 Mar; 82():463-75. PubMed ID: 14148814
    [No Abstract]   [Full Text] [Related]  

  • 7. [Note on the results of the use of new vehicles with base of polyethylene glycols].
    LAPIERE S; OLIVIER J
    Arch Belg Dermatol Syphiligr; 1952 Apr; 8(1):194-200. PubMed ID: 13017634
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with polyethyleneglycols as vehicles for ointments].
    BUCHI J; BURCKHARDT W; KUTTER H; MEIER P
    Pharm Acta Helv; 1952 Jan; 27(1):2-9. PubMed ID: 14941667
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of the polyethylene glycols as vehicles for intramuscular and subcutaneous Injection.
    CARPENTER CP; SHAFFER CB
    J Am Pharm Assoc Am Pharm Assoc; 1952 Jan; 41(1):27-9. PubMed ID: 14907489
    [No Abstract]   [Full Text] [Related]  

  • 10. A note on a contraindication to propylene glycol, as a solvent in toxicity studies.
    LAMPE KF; EASTERDAY OD
    J Am Pharm Assoc Am Pharm Assoc; 1953 Jul; 42(7):445. PubMed ID: 13069346
    [No Abstract]   [Full Text] [Related]  

  • 11. Rectal administration of drugs.
    Senior N
    Adv Pharm Sci; 1974; 4():363-435. PubMed ID: 4618035
    [No Abstract]   [Full Text] [Related]  

  • 12. [A washable polyethylene glycol ointment base].
    SCHMID J
    Pharmazie; 1956 Jan; 11(1):18-20. PubMed ID: 13322601
    [No Abstract]   [Full Text] [Related]  

  • 13. SEPHADEX CATION EXCHANGERS AS CARRIERS OF DRUG COMPONENTS FOR IMPROVEMENT OF THEIR PALATABILITY, A PRELIMINARY STUDY.
    SPROSS B; RYDE M; NYSTROEM B
    Acta Pharm Suec; 1965 Feb; 2():1-12. PubMed ID: 14270400
    [No Abstract]   [Full Text] [Related]  

  • 14. Preparation and in vitro characterization of non-effervescent floating drug delivery system of poorly soluble drug, carvedilol phosphate.
    Srikanth Meka V; Wee Liang VA; Dharmalingham SR; Sheshala R; Gorajana A
    Acta Pharm; 2014 Dec; 64(4):485-94. PubMed ID: 25531788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Action of certain macro-molecular polymers with special reference to dextran and polyvinylpyrrolidone on phagocytic function of the reticulo-endothelial system].
    BIOZZI G; HALPERN BN; BENACERRAF B; STIFFEL C; MOUTON D
    C R Seances Soc Biol Fil; 1956; 150(2):317-21. PubMed ID: 13343664
    [No Abstract]   [Full Text] [Related]  

  • 16. [Correlations between macromolecular adjuvants and drugs].
    Keipert S; Becker J; Schultze HH; Voigt R
    Pharmazie; 1973 Mar; 28(3):145-83. PubMed ID: 4573486
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intravenous use of the polyvalent alcohols, 1,3-butyleneglycol and 1,2-propyleneglycol].
    KLEINSORG H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1953; 218(1-2):103-5. PubMed ID: 13087321
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments.
    O'Shea JP; Faisal W; Ruane-O'Hora T; Devine KJ; Kostewicz ES; O'Driscoll CM; Griffin BT
    Eur J Pharm Biopharm; 2015 Oct; 96():207-16. PubMed ID: 26215636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of watersoluble macromolecular compounds on natural and antibody-sensitized erythrocytes. II. Studies on variously highmolecular preparations of dextran, polyethylenglycol and polyvinylpyrolliden].
    Hummel K; Weniger J
    Z Immunitatsforsch Allerg Klin Immunol; 1968 May; 135(3):219-36. PubMed ID: 4234959
    [No Abstract]   [Full Text] [Related]  

  • 20. [RAPID METHOD FOR THE DETERMINATION OF TRYPSIN IN PREPARATIONS WITH LIPID VEHICLES].
    CASTELLI B
    Farmaco Prat; 1964 Mar; 19():151-4. PubMed ID: 14142802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.